TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Youlden, D. R. AU - Cramb, S. M. AU - Dunn, N. A. AU - Muller, J. M. AU - Pyke, C. M. AU - Baade, P. D. PY - 2012 DA - 2012// TI - The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality JO - Cancer Epidemiol VL - 36 UR - https://doi.org/10.1016/j.canep.2012.02.007 DO - 10.1016/j.canep.2012.02.007 ID - Youlden2012 ER - TY - JOUR AU - Bulfoni, M. AU - Turetta, M. AU - Del Ben, F. AU - Di Loreto, C. AU - Beltrami, A. P. AU - Cesselli, D. PY - 2016 DA - 2016// TI - Dissecting the heterogeneity of circulating tumor cells in metastatic breast Cancer: going far beyond the needle in the haystack JO - Int J Mol Sci VL - 17 UR - https://doi.org/10.3390/ijms17101775 DO - 10.3390/ijms17101775 ID - Bulfoni2016 ER - TY - JOUR AU - Das, V. AU - Kalyan, G. AU - Hazra, S. AU - Pal, M. PY - 2017 DA - 2017// TI - Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast Cancer JO - J Cell Physiol VL - 233 UR - https://doi.org/10.1002/jcp.25821 DO - 10.1002/jcp.25821 ID - Das2017 ER - TY - JOUR AU - Di Leo, A. AU - Curigliano, G. AU - Dieras, V. AU - Malorni, L. AU - Sotiriou, C. AU - Swanton, C. AU - Thompson, A. AU - Tutt, A. AU - Piccart, M. PY - 2015 DA - 2015// TI - New approaches for improving outcomes in breast cancer in Europe JO - Breast VL - 24 UR - https://doi.org/10.1016/j.breast.2015.03.001 DO - 10.1016/j.breast.2015.03.001 ID - Di Leo2015 ER - TY - JOUR AU - Klukovits, A. AU - Krajcsi, P. PY - 2015 DA - 2015// TI - Mechanisms and therapeutic potential of inhibiting drug efflux transporters JO - Expert Opin Drug Metab Toxicol VL - 11 UR - https://doi.org/10.1517/17425255.2015.1028917 DO - 10.1517/17425255.2015.1028917 ID - Klukovits2015 ER - TY - JOUR AU - Goodsell, D. S. PY - 2002 DA - 2002// TI - The molecular perspective: DNA topoisomerases JO - Stem Cells VL - 20 UR - https://doi.org/10.1634/stemcells.20-5-470 DO - 10.1634/stemcells.20-5-470 ID - Goodsell2002 ER - TY - JOUR AU - Jeppsson, K. AU - Kanno, T. AU - Shirahige, K. AU - Sjogren, C. PY - 2014 DA - 2014// TI - The maintenance of chromosome structure: positioning and functioning of SMC complexes JO - Nat Rev Mol Cell Biol VL - 15 UR - https://doi.org/10.1038/nrm3857 DO - 10.1038/nrm3857 ID - Jeppsson2014 ER - TY - JOUR AU - Yersal, O. AU - Barutca, S. PY - 2014 DA - 2014// TI - Biological subtypes of breast cancer: prognostic and therapeutic implications JO - World J Clin Oncol VL - 5 UR - https://doi.org/10.5306/wjco.v5.i3.412 DO - 10.5306/wjco.v5.i3.412 ID - Yersal2014 ER - TY - JOUR AU - Nitiss, J. L. PY - 2009 DA - 2009// TI - Targeting DNA topoisomerase II in cancer chemotherapy JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2607 DO - 10.1038/nrc2607 ID - Nitiss2009 ER - TY - JOUR AU - van Hille, B. AU - Etievant, C. AU - Barret, J. M. AU - Kruczynski, A. AU - Hill, B. T. PY - 2000 DA - 2000// TI - Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action JO - Anti-Cancer Drugs VL - 11 UR - https://doi.org/10.1097/00001813-200011000-00007 DO - 10.1097/00001813-200011000-00007 ID - van Hille2000 ER - TY - JOUR AU - Wang, J. C. PY - 2002 DA - 2002// TI - Cellular roles of DNA topoisomerases: a molecular perspective JO - Nat Rev Mol Cell Biol VL - 3 UR - https://doi.org/10.1038/nrm831 DO - 10.1038/nrm831 ID - Wang2002 ER - TY - JOUR AU - Champoux, J. J. PY - 2001 DA - 2001// TI - DNA topoisomerases: structure, function, and mechanism JO - Annu Rev Biochem VL - 70 UR - https://doi.org/10.1146/annurev.biochem.70.1.369 DO - 10.1146/annurev.biochem.70.1.369 ID - Champoux2001 ER - TY - JOUR AU - Deweese, J. E. AU - Osheroff, N. PY - 2009 DA - 2009// TI - The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing JO - Nucleic Acids Res VL - 37 UR - https://doi.org/10.1093/nar/gkn937 DO - 10.1093/nar/gkn937 ID - Deweese2009 ER - TY - JOUR AU - Clark, P. I. AU - Slevin, M. L. PY - 1987 DA - 1987// TI - The clinical pharmacology of etoposide and teniposide JO - Clin Pharmacokinet VL - 12 UR - https://doi.org/10.2165/00003088-198712040-00001 DO - 10.2165/00003088-198712040-00001 ID - Clark1987 ER - TY - JOUR AU - Suffredini, I. B. AU - Varella, A. D. AU - Younes, R. N. PY - 2006 DA - 2006// TI - Cytotoxic molecules from natural sources: tapping the Brazilian biodiversity JO - Anti Cancer Agents Med Chem VL - 6 UR - https://doi.org/10.2174/187152006777698187 DO - 10.2174/187152006777698187 ID - Suffredini2006 ER - TY - JOUR AU - Pommier, Y. PY - 2013 DA - 2013// TI - Drugging topoisomerases: lessons and challenges JO - ACS Chem Biol VL - 8 UR - https://doi.org/10.1021/cb300648v DO - 10.1021/cb300648v ID - Pommier2013 ER - TY - JOUR AU - Mladenovic, M. AU - Stankovic, N. AU - Matic, S. AU - Stanic, S. AU - Mihailovic, M. AU - Mihailovic, V. AU - Katanic, J. AU - Boroja, T. AU - Vukovic, N. PY - 2015 DA - 2015// TI - Newly discovered chroman-2,4-diones neutralize the in vivo DNA damage induced by alkylation through the inhibition of topoisomerase IIalpha: a story behind the molecular modeling approach JO - Biochem Pharmacol VL - 98 UR - https://doi.org/10.1016/j.bcp.2015.08.106 DO - 10.1016/j.bcp.2015.08.106 ID - Mladenovic2015 ER - TY - JOUR AU - Wei, N. AU - Chu, E. AU - Wu, S. Y. AU - Wipf, P. AU - Schmitz, J. C. PY - 2015 DA - 2015// TI - The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells JO - Oncotarget VL - 6 ID - Wei2015 ER - TY - JOUR AU - Wei, N. AU - Liu, G. T. AU - Chen, X. G. AU - Liu, Q. AU - Wang, F. P. AU - Sun, H. PY - 2011 DA - 2011// TI - H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2 JO - Biochem Pharmacol VL - 82 UR - https://doi.org/10.1016/j.bcp.2011.08.012 DO - 10.1016/j.bcp.2011.08.012 ID - Wei2011 ER - TY - JOUR AU - Bordoli, L. AU - Kiefer, F. AU - Arnold, K. AU - Benkert, P. AU - Battey, J. AU - Schwede, T. PY - 2009 DA - 2009// TI - Protein structure homology modeling using SWISS-MODEL workspace JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2008.197 DO - 10.1038/nprot.2008.197 ID - Bordoli2009 ER - TY - JOUR AU - Wu, C. C. AU - Li, Y. C. AU - Wang, Y. R. AU - Li, T. K. AU - Chan, N. L. PY - 2013 DA - 2013// TI - On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs JO - Nucleic Acids Res VL - 41 UR - https://doi.org/10.1093/nar/gkt828 DO - 10.1093/nar/gkt828 ID - Wu2013 ER - TY - JOUR AU - Verdonk, M. L. AU - Cole, J. C. AU - Hartshorn, M. J. AU - Murray, C. W. AU - Taylor, R. D. PY - 2003 DA - 2003// TI - Improved protein-ligand docking using GOLD JO - Proteins VL - 52 UR - https://doi.org/10.1002/prot.10465 DO - 10.1002/prot.10465 ID - Verdonk2003 ER - TY - JOUR AU - Nair, R. S. AU - Potti, M. E. AU - Thankappan, R. AU - Chandrika, S. K. AU - Kurup, M. R. AU - Srinivas, P. PY - 2017 DA - 2017// TI - Molecular trail for the anticancer behavior of a novel copper carbohydrazone complex in BRCA1 mutated breast cancer JO - Mol Carcinog VL - 56 UR - https://doi.org/10.1002/mc.22610 DO - 10.1002/mc.22610 ID - Nair2017 ER - TY - JOUR AU - Youle, R. J. AU - Strasser, A. PY - 2008 DA - 2008// TI - The BCL-2 protein family: opposing activities that mediate cell death JO - Nat Rev Mol Cell Biol VL - 9 UR - https://doi.org/10.1038/nrm2308 DO - 10.1038/nrm2308 ID - Youle2008 ER - TY - JOUR AU - Li, X. Y. AU - Li, Y. AU - Zhang, Y. AU - Wang, K. AU - Yuan, X. AU - Jin, J. AU - Zhang, Y. AU - Liu, Z. Z. AU - Chen, X. G. PY - 2011 DA - 2011// TI - A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cbeta pathway, in chronic myelogenous leukemia K562 cells JO - Leuk Lymphoma VL - 52 UR - https://doi.org/10.3109/10428194.2011.565393 DO - 10.3109/10428194.2011.565393 ID - Li2011 ER - TY - JOUR AU - Zhang, Y. X. AU - Liu, X. M. AU - Wang, J. AU - Li, J. AU - Liu, Y. AU - Zhang, H. AU - Yu, X. W. AU - Wei, N. PY - 2015 DA - 2015// TI - Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: a derivative of tetrandrine JO - Cancer Biol Ther VL - 16 UR - https://doi.org/10.1080/15384047.2015.1040950 DO - 10.1080/15384047.2015.1040950 ID - Zhang2015 ER - TY - JOUR AU - Wee, K. B. AU - Aguda, B. D. PY - 2006 DA - 2006// TI - Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death JO - Biophys J VL - 91 UR - https://doi.org/10.1529/biophysj.105.077693 DO - 10.1529/biophysj.105.077693 ID - Wee2006 ER - TY - JOUR AU - Deweese, J. E. AU - Osheroff, M. A. AU - Osheroff, N. PY - 2008 DA - 2008// TI - DNA topology and topoisomerases: teaching a “knotty” subject JO - Biochem Mol Biol Educ VL - 37 UR - https://doi.org/10.1002/bmb.20244 DO - 10.1002/bmb.20244 ID - Deweese2008 ER - TY - JOUR AU - Wray, J. AU - Williamson, E. A. AU - Royce, M. AU - Shaheen, M. AU - Beck, B. D. AU - Lee, S. H. AU - Nickoloff, J. A. AU - Hromas, R. PY - 2009 DA - 2009// TI - Metnase mediates resistance to topoisomerase II inhibitors in breast cancer cells JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0005323 DO - 10.1371/journal.pone.0005323 ID - Wray2009 ER - TY - JOUR AU - Ghosal, G. AU - Chen, J. PY - 2013 DA - 2013// TI - DNA damage tolerance: a double-edged sword guarding the genome JO - Transl Cancer Res VL - 2 ID - Ghosal2013 ER - TY - JOUR AU - Marechal, A. AU - Zou, L. PY - 2013 DA - 2013// TI - DNA damage sensing by the ATM and ATR kinases JO - Cold Spring Harb Perspect Biol VL - 5 UR - https://doi.org/10.1101/cshperspect.a012716 DO - 10.1101/cshperspect.a012716 ID - Marechal2013 ER - TY - JOUR AU - Iliakis, G. AU - Wang, Y. AU - Guan, J. AU - Wang, H. PY - 2003 DA - 2003// TI - DNA damage checkpoint control in cells exposed to ionizing radiation JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206682 DO - 10.1038/sj.onc.1206682 ID - Iliakis2003 ER - TY - JOUR AU - Evans, M. D. AU - Dizdaroglu, M. AU - Cooke, M. S. PY - 2004 DA - 2004// TI - Oxidative DNA damage and disease: induction, repair and significance JO - Mutat Res VL - 567 UR - https://doi.org/10.1016/j.mrrev.2003.11.001 DO - 10.1016/j.mrrev.2003.11.001 ID - Evans2004 ER - TY - JOUR AU - Zhang, Y. AU - Karki, R. AU - Igwe, O. J. PY - 2015 DA - 2015// TI - Toll-like receptor 4 signaling: a common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation JO - Biochem Pharmacol VL - 98 UR - https://doi.org/10.1016/j.bcp.2015.08.109 DO - 10.1016/j.bcp.2015.08.109 ID - Zhang2015 ER - TY - JOUR AU - Karki, R. AU - Zhang, Y. AU - Igwe, O. J. PY - 2014 DA - 2014// TI - Activation of c-Src: a hub for exogenous pro-oxidant-mediated activation of toll-like receptor 4 signaling JO - Free Radic Biol Med VL - 71 UR - https://doi.org/10.1016/j.freeradbiomed.2014.03.005 DO - 10.1016/j.freeradbiomed.2014.03.005 ID - Karki2014 ER - TY - JOUR AU - Zhang, Y. AU - Igwe, O. J. PY - 2018 DA - 2018// TI - Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E2 biosynthesis in primary murine macrophages JO - Int Immunopharmacol VL - 54 UR - https://doi.org/10.1016/j.intimp.2017.11.017 DO - 10.1016/j.intimp.2017.11.017 ID - Zhang2018 ER - TY - JOUR AU - Ogawara, Y. AU - Kishishita, S. AU - Obata, T. AU - Isazawa, Y. AU - Suzuki, T. AU - Tanaka, K. AU - Masuyama, N. AU - Gotoh, Y. PY - 2002 DA - 2002// TI - Akt enhances Mdm2-mediated ubiquitination and degradation of p53 JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M109745200 DO - 10.1074/jbc.M109745200 ID - Ogawara2002 ER -